Jai-Hyun Kwon

Title: Innovations of Jai-Hyun Kwon in Insulin Delivery Systems.

Introduction

Jai-Hyun Kwon is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of insulin delivery systems. His innovative approach focuses on enhancing the stability and efficacy of insulin preparations.

Latest Patents

One of Jai-Hyun Kwon's key patents is titled "Controlled release preparation of insulin and its method." This patent describes a controlled release preparation that utilizes microparticles obtained through the microencapsulation of uniform microcrystals of insulin using biodegradable polymeric materials. The method significantly reduces the denaturation of insulin during microencapsulation, thereby increasing the stability of the preparation. Additionally, the ratio of insulin to the polymer carrier is optimized for pulmonary delivery, allowing for continuous pharmaceutical efficacy in vivo over an extended period.

Career Highlights

Jai-Hyun Kwon is associated with M.i.tech Co., Ltd., where he applies his expertise in pharmaceutical innovations. His work has been instrumental in advancing drug delivery systems, particularly for insulin, which is crucial for diabetes management.

Collaborations

Jai-Hyun Kwon has collaborated with notable colleagues, including Chan-Hwa Kim and Sung-Hee Choi. Their combined efforts have contributed to the development of advanced pharmaceutical technologies.

Conclusion

Jai-Hyun Kwon's innovative work in controlled release insulin preparations showcases his commitment to improving healthcare solutions. His contributions are vital for enhancing the quality of life for individuals requiring insulin therapy.